Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
SynKinase
Danusertib
CHF 0.00
In stock
SYN-1095-M0011 mgCHF 149.00
SYN-1095-M0055 mgCHF 241.00
SYN-1095-M01010 mgCHF 440.00
SYN-1095-M05050 mgCHF 1'348.00
SYN-1095-M100100 mgINQ
| Product Details | |
|---|---|
| Synonyms | PHA-739358 |
| Product Type | Chemical |
| Properties | |
| Formula |
C26H30N6O3 |
| MW | 474.6 |
| CAS | 827318-97-8 |
| Purity Chemicals | ≥95% |
| Appearance | Solid. |
| Solubility | Soluble in DMSO or ethanol. |
| Declaration | Manufactured by SynKinase. |
| Other Product Data |
Target: Abl - Aurora A - BCR - FGFR | Kinase Group: Other | Substrate: Serine-Threonine |
| InChi Key | XKFTZKGMDDZMJI-HSZRJFAPSA-N |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
Aurora kinases are key regulators of protein phosphorylation during mitosis, and these serine/threonine kinases interact with other cellular proteins to help control chromosome assembly and segregation during mitosis. Aurora kinases are often highly expressed in malignancies and solid tumors. Danusertib (PHA-739358) is a small molecule pan- Aurora kinase inhibitor that also has activity against other cancer-relevant kinases such as Bcr-Abl tyrosine kinase. Other off target effects of danusertib include inhibition of receptor tyrosine kinases such as FGFR-1, and TrkA. Danusertib demonstrates nanomolar IC(50) values for the Aurora kinases all under 100nM and it also demonstrates potent anti-proliferation effects in cell proliferation assays with IC(50) values ranging from 20nM for A2780 cells to <200nM.
Product References
- 1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: identification of a potent Aurora kinase inhibitor with a favorable antitumor kinase inhibition profile: D. Fancelli, et al.; J. Med. Chem. 49, 7247 (2006)
- Targeting aurora kinases with danusertib (PHA-739358) inhibits growth of liver metastases from gastroenteropancreatic neuroendocrine tumors in an orthotopic xenograft model: K. Fraedrich, et al.; Clin. Cancer Res. 18, 4621 (2012)
- Splice Modulation Synergizes Cell Cycle Inhibition: A. Kelsey, et al.; ACS Chem. Biol. ahead of print (2020)
Related Products
